What exercise regimen is recommended for a stable adult patient with chronic heart failure (NYHA class II‑III) who is on optimized therapy including an ACE inhibitor or ARB, a beta‑blocker (e.g., carvedilol or metoprolol succinate), and a mineralocorticoid receptor antagonist if indicated?

Exercise Prescription for Heart Failure Patients

Stable chronic heart failure patients (NYHA class II-III) on optimized medical therapy should engage in supervised aerobic exercise training at 40-80% of peak VO2 (or 60-80% of peak heart rate), 3-5 days per week for 30-60 minutes per session, with interval training preferred over continuous training to minimize cardiac stress while maximizing peripheral benefits. 1, 2

Core Exercise Regimen

Aerobic Training Structure

Interval training is superior to continuous exercise for heart failure patients because it delivers high peripheral training stimuli without significantly elevating heart rate, which is critical for myocardial recovery 1. The protocol involves:

• Work phases: 60-90 seconds at high intensity (determined by steep ramp test)
• Recovery phases: 60 seconds at low intensity
• Modality: Cycle ergometer preferred; treadmill acceptable with 60-second intervals
• Frequency: 3-5 days per week 3
• Duration: 30-60 minutes per session 3

Intensity Guidelines

Three validated approaches exist for determining intensity 1:

1. VO2-based: 40-80% of peak VO2 (patients with lower baseline tolerance respond to lower intensities)
2. Heart rate-based: 60-80% of peak heart rate or heart rate reserve
3. Perceived exertion: Borg scale <13 ("somewhat hard") is well-tolerated

Critical safety parameter: Training heart rate should be kept as low as feasible since long-term heart rate reduction is essential for myocardial recovery 1. This principle favors interval training over continuous exercise.

Progression Algorithm

Follow this strict sequence 1:

1. First: Increase duration
2. Second: Increase frequency
3. Last: Increase intensity

Timeline:

• Initial stage: First 2-4 weeks with close monitoring
• Improvement stage: Months 1-6 with gradual progression
• Maintenance stage: After 6 months, continue indefinitely to prevent deconditioning 1

Complementary Training Modalities

Resistance Training (Callisthenics)

• Position: Sitting preferred to minimize preload/afterload increases
• Arm position: Keep at body level (avoid overhead)
• Speed: Moderate to slow with rhythmic breathing
• Frequency: Integrated into aerobic sessions 1

Respiratory Muscle Training

Inspiratory muscle training using threshold devices 1, 4:

• Intensity: 25-35% of maximum inspiratory pressure (PI max)
• Duration: 20-30 minutes per day
• Frequency: 3-5 days weekly
• Benefits: Improves inspiratory muscle strength, exercise capacity, and quality of life

Mandatory Safety Monitoring

Supervised, in-hospital training is required initially to verify individual responses and clinical stability 1. This is particularly important given that most research excluded high-risk patients.

Pre-Exercise Assessment

• Pulmonary and cardiac auscultation
• Body weight and peripheral edema check
• Heart rate, blood pressure, rhythm monitoring

During Exercise Monitoring

• Continuous heart rate and rhythm
• Blood pressure (10-20 mmHg systolic increase acceptable if asymptomatic)
• Symptom surveillance (dyspnea and fatigue rated separately)

Immediate Termination Criteria 1

• Acute blood pressure decrease
• Onset of angina
• Significant dyspnea or fatigue beyond baseline
• Feeling of exhaustion
• Serious exercise-induced arrhythmias

Medication Considerations

Beta-blocker therapy (metoprolol succinate, carvedilol) may limit heart rate response during exercise 5. If symptomatic bradycardia occurs during training, reduce beta-blocker dose rather than abandoning exercise 5. The force-frequency relationship is impaired in heart failure, making lower training heart rates preferable 1.

Clinical Outcomes

Exercise training in NYHA class II-III patients achieves 2, 6, 7:

• Enhanced exercise capacity (32-49% improvement in peak VO2)
• Improved quality of life
• Reduced hospitalizations
• Potential mortality reduction
• Reverse cardiac remodeling (7% reduction in LV end-diastolic diameter)
• 27-32% increase in stroke volume

Critical caveat: Effects are lost within 3 weeks of detraining, necessitating lifelong continuation 1.

Common Pitfalls

1. Starting too aggressively: Begin conservatively and progress systematically
2. Ignoring worsening symptoms: Temporary heart failure exacerbation requires increased diuretics and temporary exercise reduction 5
3. Inadequate supervision: Initial unsupervised training risks adverse events
4. Using only continuous training: Interval training provides superior benefits with lower cardiac stress 1
5. Stopping after 6 months: Maintenance training must continue indefinitely 1